Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Genotypic correlates of phenotypic resistance to efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapy.
Bacheler L, Jeffrey S, Hanna G, D'Aquila R, Wallace L, Logue K, Cordova B, Hertogs K, Larder B, Buckery R, Baker D, Gallagher K, Scarnati H, Tritch R, Rizzo C. Bacheler L, et al. Among authors: hertogs k. J Virol. 2001 Jun;75(11):4999-5008. doi: 10.1128/JVI.75.11.4999-5008.2001. J Virol. 2001. PMID: 11333879 Free PMC article.
Drug-resistant reverse transcriptase genotyping and phenotyping of B and non-B subtypes (F and A) of human immunodeficiency virus type I found in Brazilian patients failing HAART.
Caride E, Brindeiro R, Hertogs K, Larder B, Dehertogh P, Machado E, de Sá CA, Eyer-Silva WA, Sion FS, Passioni LF, Menezes JA, Calazans AR, Tanuri A. Caride E, et al. Among authors: hertogs k. Virology. 2000 Sep 15;275(1):107-15. doi: 10.1006/viro.2000.0487. Virology. 2000. PMID: 11017792 Free article.
Correlation of phenotypic zidovudine resistance with mutational patterns in the reverse transcriptase of human immunodeficiency virus type 1: interpretation of established mutations and characterization of new polymorphisms at codons 208, 211, and 214.
Stürmer M, Staszewski S, Doerr HW, Larder B, Bloor S, Hertogs K. Stürmer M, et al. Among authors: hertogs k. Antimicrob Agents Chemother. 2003 Jan;47(1):54-61. doi: 10.1128/AAC.47.1.54-61.2003. Antimicrob Agents Chemother. 2003. PMID: 12499169 Free PMC article.
A family of insertion mutations between codons 67 and 70 of human immunodeficiency virus type 1 reverse transcriptase confer multinucleoside analog resistance.
Larder BA, Bloor S, Kemp SD, Hertogs K, Desmet RL, Miller V, Sturmer M, Staszewski S, Ren J, Stammers DK, Stuart DI, Pauwels R. Larder BA, et al. Among authors: hertogs k. Antimicrob Agents Chemother. 1999 Aug;43(8):1961-7. doi: 10.1128/AAC.43.8.1961. Antimicrob Agents Chemother. 1999. PMID: 10428920 Free PMC article.
A novel human immunodeficiency virus type 1 reverse transcriptase mutational pattern confers phenotypic lamivudine resistance in the absence of mutation 184V.
Hertogs K, Bloor S, De Vroey V, van Den Eynde C, Dehertogh P, van Cauwenberge A, Stürmer M, Alcorn T, Wegner S, van Houtte M, Miller V, Larder BA. Hertogs K, et al. Antimicrob Agents Chemother. 2000 Mar;44(3):568-73. doi: 10.1128/AAC.44.3.568-573.2000. Antimicrob Agents Chemother. 2000. PMID: 10681319 Free PMC article.
Evaluation of lymph node virus burden in human immunodeficiency virus-infected patients receiving efavirenz-based protease inhibitor--sparing highly active antiretroviral therapy.
Dybul M, Chun TW, Ward DJ, Hertogs K, Larder B, Fox CH, Orenstein JM, Baird BF, Li Y, Green LG, Engel D, Liu S, Mican JM, Fauci AS. Dybul M, et al. Among authors: hertogs k. J Infect Dis. 2000 Apr;181(4):1273-9. doi: 10.1086/315407. J Infect Dis. 2000. PMID: 10836864 Clinical Trial.
97 results